Profiles of epigenetic histone post-translational modifications at type 1 diabetes susceptible genes

Journal of Biological Chemistry

Volumn 287, Issue 20, 2012, Pages 16335-16345

  Miao, Feng ^a   Chen, Zhuo ^a   Zhang, Lingxiao ^a   Liu, Zheng ^a   Wu, Xiwei ^a   Yuan, Yate Ching ^a   Natarajan, Rama ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CELLS; CHROMATIN IMMUNOPRECIPITATION; DATA SETS; ENVIRONMENTAL FACTORS; EXTERNAL STIMULUS; FUNCTIONAL ASSOCIATIONS; HEALTHY CONTROLS; INSULIN-DEPENDENT DIABETES MELLITUS; NON-DIABETIC CONTROL; POST-TRANSLATIONAL MODIFICATIONS; POTENTIAL VARIATIONS; PROMOTER REGION; TRANSCRIPTIONAL RESPONSE; TRIMETHYLATION; TYPE 1 DIABETES; UPSTREAM REGION;

ACETYLATION; AMINO ACIDS; BODY FLUIDS; PATIENT TREATMENT;

GENES;

GAMMA INTERFERON; HISTONE; HISTONE H3; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; LYSINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DIABETOGENESIS; ENHANCER REGION; EPIGENETICS; GENE; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HISTONE MODIFICATION; HLA DQB1 GENE; HLA DRB1 GENE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; MICROARRAY ANALYSIS; MONOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION;

DIABETES MELLITUS, TYPE 1; EPIGENESIS, GENETIC; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84860849822     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.330373     Document Type: Article

References (50)

1. Pociot, F., Akolkar, B., Concannon, P., Erlich, H. A., Julier, C., Morahan, G., Nierras, C. R., Todd, J. A., Rich, S. S., and Nerup, J. (2010) Genetics of type 1 diabetes. What's next? Diabetes 59, 1561-1571
2. Eisenbarth, G. S. (2010) Banting Lecture 2009, an unfinished journey. Molecular pathogenesis to prevention of type 1A diabetes. Diabetes 59, 759-774
3. Concannon, P., Rich, S. S., and Nepom, G. T. (2009) Genetics of type 1A diabetes. N. Engl. J. Med. 360, 1646-1654
4. Todd, J. A. (2010) Etiology of type 1 diabetes. Immunity 32, 457-467
5. Nerup, J., Platz, P., Andersen, O. O., Christy, M., Lyngsoe, J., Poulsen, J. E., Ryder, L. P., Nielsen, L. S., Thomsen, M., and Svejgaard, A. (1974) HL-A antigens and diabetes melittis. Lancet 2, 864-866
6. Mein, C. A., Esposito, L., Dunn, M. G., Johnson, G. C., Timms, A. E., Goy, J. V., Smith, A. N., Sebag-Montefiore, L., Merriman, M. E., Wilson, A. J., Pritchard, L. E., Cucca, F., Barnett, A. H., Bain, S. C., and Todd, J. A. (1998) A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat. Genet. 19, 297-300 (Pubitemid 28309348)
7. Davies, J. L., Kawaguchi, Y., Bennett, S. T., Copeman, J. B., Cordell, H. J., Pritchard, L. E., Reed, P. W., Gough, S. C., Jenkins, S. C., and Palmer, S. M. (1994) A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371, 130-136 (Pubitemid 24284009)
8. Aly, T. A., Eller, E., Ide, A., Gowan, K., Babu, S. R., Erlich, H. A., Rewers, M. J., Eisenbarth, G. S., and Fain, P. R. (2006) Multi-SNP analysis of MHC region. Remarkable conservation of HLA-A1-B8-DR3 haplotype. Diabetes 55, 1265-1269 (Pubitemid 44195363)
9. Aly, T. A., Ide, A., Jahromi, M. M., Barker, J. M., Fernando, M. S., Babu, S. R., Yu, L., Miao, D., Erlich, H. A., Fain, P. R., Barriga, K. J., Norris, J. M., Rewers, M. J., and Eisenbarth, G. S. (2006) Extreme genetic risk for type 1A diabetes. Proc. Natl. Acad. Sci. U.S.A. 103, 14074-14079 (Pubitemid 44452982)
10. Peng, H., and Hagopian, W. (2006) Environmental factors in the development of type 1 diabetes. Rev. Endocr. Metab. Dis. 7, 149-162 (Pubitemid 46084826)
11. Villeneuve, L. M., and Natarajan, R. (2010) The role of epigenetics in the pathology of diabetic complications. Am. J. Physiol. Renal Physiol 299, F14-25
12. Litherland, S. A. (2008) Immunopathogenic interaction of environmental triggers and genetic susceptibility in diabetes. Is epigenetics the missing link? Diabetes 57, 3184-3186
13. Harjutsalo, V., Sjöberg, L., and Tuomilehto, J. (2008) Time trends in the incidence of type 1 diabetes in Finnish children. A cohort study. Lancet 371, 1777-1782 (Pubitemid 351697953)
14. Jirtle, R. L., and Skinner, M. K. (2007) Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253-262 (Pubitemid 46439287)
15. Klug, A., Rhodes, D., Smith, J., Finch, J. T., and Thomas, J. O. (1980) A low resolution structure for the histone core of the nucleosome. Nature 287, 509-516 (Pubitemid 11232848)
16. Strahl, B. D., and Allis, C. D. (2000) The language of covalent histone modifications. Nature 403, 41-45 (Pubitemid 30038513)
17. Zhang, Y., and Reinberg, D. (2001) Transcription regulation by histone methylation. Interplay between different covalent modifications of the core histone tails. Genes Dev. 15, 2343-2360 (Pubitemid 32899739)
18. Shilatifard, A. (2006) Chromatin modifications by methylation and ubiquitination. Implications in the regulation of gene expression. Annu. Rev. Biochem. 75, 243-269
19. Campos, E. I., and Reinberg, D. (2009) Histones, annotating chromatin. Annu. Rev. Genet. 43, 559-599
20. Bird, A. (2007) Perceptions of epigenetics. Nature 447, 396-398
21. Berger, S. L., Kouzarides, T., Shiekhattar, R., and Shilatifard, A. (2009) An operational definition of epigenetics. Genes Dev. 23, 781-783
22. Smith, E., and Shilatifard, A. (2010) The chromatin signaling pathway. Diverse mechanisms of recruitment of histone-modifying enzymes and varied biological outcomes. Mol. Cell 40, 689-701
23. Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., Lunke, S., Ziemann, M., Karagiannis, T., Tonna, S., Kowalczyk, A., Beresford-Smith, B., Macintyre, G., Kelong, M., Hongyu, Z., Zhu, J., and El-Osta, A. (2011) Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 21, 1601-1615
24. Miao, F., Gonzalo, I. G., Lanting, L., and Natarajan, R. (2004) In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J. Biol. Chem. 279, 18091-18097 (Pubitemid 38560579)
25. Miao, F., Wu, X., Zhang, L., Yuan, Y. C., Riggs, A. D., and Natarajan, R. (2007) Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J. Biol. Chem. 282, 13854-13863 (Pubitemid 47100501)
26. Villeneuve, L. M., Reddy, M. A., Lanting, L. L., Wang, M., Meng, L., and Natarajan, R. (2008) Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl. Acad. Sci. U.S.A. 105, 9047-9052
27. El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., and Brownlee, M. (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409-2417
28. Miao, F., Smith, D. D., Zhang, L., Min, A., Feng, W., and Natarajan, R. (2008) Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation. An epigenetic study in diabetes. Diabetes 57, 3189-3198
29. Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., and El-Osta, A. (2009) Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58, 1229-1236
30. Sun, G., Reddy, M. A., Yuan, H., Lanting, L., Kato, M., and Natarajan, R. (2010) Epigenetic histone methylation modulates fibrotic gene expression. J. Am. Soc. Nephrol. 12, 2069-2080
31. Ren, B., Robert, F., Wyrick, J. J., Aparicio, O., Jennings, E. G., Simon, I., Zeitlinger, J., Schreiber, J., Hannett, N., Kanin, E., Volkert, T. L., Wilson, C. J., Bell, S. P., and Young, R. A. (2000) Genome-wide location and function of DNA binding proteins. Science 290, 2306-2309 (Pubitemid 32041573)
32. Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (Pubitemid 46802390)
33. Hawkins, R. D., Hon, G. C., and Ren, B. (2010) Next-generation genomics. An integrative approach. Nat. Rev. Genet 11, 476-486
34. Barrett, J. C., Clayton, D. G., Concannon, P., Akolkar, B., Cooper, J. D., Erlich, H. A., Julier, C., Morahan, G., Nerup, J., Nierras, C., Plagnol, V., Pociot, F., Schuilenburg, H., Smyth, D. J., Stevens, H., Todd, J. A., Walker, N. M., and Rich, S. S. (2009) Genome-wide association study and metaanalysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 41, 703-707
35. Bluestone, J. A., Herold, K., and Eisenbarth, G. (2010) Genetics, pathogenesis, and clinical interventions in type 1 diabetes. Nature 464, 1293-1300
36. Vandiedonck, C., and Knight, J. C. (2009) The human major histocompatibility complex as a paradigm in genomics research. Brief. Funct. Genomics Proteomics 8, 379-394
37. Dausset, J. (1981) The major histocompatibility complex in man. Science 213, 1469-1474
38. Cheong, C., Matos, I., Choi, J. H., Dandamudi, D. B., Shrestha, E., Longhi, M. P., Jeffrey, K. L., Anthony, R. M., Kluger, C., Nchinda, G., Koh, H., Rodriguez, A., Idoyaga, J., Pack, M., Velinzon, K., Park, C. G., and Steinman, R. M. (2010) Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143, 416-429
39. Bieda, M., Xu, X., Singer, M. A., Green, R., and Farnham, P. J. (2006) Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 16, 595-605
40. Choi, N. M., Majumder, P., and Boss, J. M. (2011) Regulation of major histocompatibility complex class II genes. Curr. Opin Immunol. 23, 81-87
41. Masternak, K., Muhlethaler-Mottet, A., Villard, J., Zufferey, M., Steimle, V., and Reith, W. (2000) CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14, 1156-1166 (Pubitemid 30324428)
42. Majumder, P., Gomez, J. A., Chadwick, B. P., and Boss, J. M. (2008) The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions. J. Exp. Med. 205, 785-798 (Pubitemid 351549878)
43. Majumder, P., and Boss, J. M. (2010) CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus. Mol. Cell. Biol. 30, 4211-4223
44. Arenzana-Seisdedos, F., Mogensen, S. C., Vuillier, F., Fiers, W., and Virelizier, J. L. (1988) Autocrine secretion of tumor necrosis factor under the influence of interferon-γ amplifies HLA-DR gene induction in human monocytes. Proc. Natl. Acad. Sci. U.S.A. 85, 6087-6091
45. Masternak, K., Peyraud, N., Krawczyk, M., Barras, E., and Reith, W. (2003) Chromatin remodeling and extragenic transcription at the MHC class II locus control region. Nat. Immunol. 4, 132-137 (Pubitemid 36193014)
46. Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., Ching, K. A., Antosiewicz-Bourget, J. E., Liu, H., Zhang, X., Green, R. D., Lobanenkov, V. V., Stewart, R., Thomson, J. A., Crawford, G. E., Kellis, M., and Ren, B. (2009) Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112
47. Visel, A., Blow, M. J., Li, Z., Zhang, T., Akiyama, J. A., Holt, A., Plajzer-Frick, I., Shoukry, M., Wright, C., Chen, F., Afzal, V., Ren, B., Rubin, E. M., and Pennacchio, L. A. (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858
48. Todd, J. A., Bell, J. I., and McDevitt, H. O. (1987) HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599-604 (Pubitemid 17140111)
49. Todd, J. A., Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., Field, S. F., Payne, F., Lowe, C. E., Szeszko, J. S., Hafler, J. P., Zeitels, L., Yang, J. H., Vella, A., Nutland, S., Stevens, H. E., Schuilenburg, H., Coleman, G., Maisuria, M., Meadows, W., Smink, L. J., Healy, B., Burren, O. S., Lam, A. A., Ovington, N. R., Allen, J., Adlem, E., Leung, H. T., Wallace, C., Howson, J. M., Guja, C., Ionescu-Tîrgovişte, C., Simmonds, M. J., Heward, J. M., Gough, S. C., Dunger, D. B., Wicker, L. S., and Clayton, D. G. (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857-864 (Pubitemid 47018195)
50. Seydel, F., Garrigan, E., Stutevoss, B., Belkin, N., Makadia, B., Carter, J., Shi, J. D., Davoodi-Semiromi, A., McDuffie, M., and Litherland, S. A. (2008) GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of nonobese diabetic (NOD) mouse myeloid cells. J. Autoimmun. 31, 377-384